Skip to Content
Our Picks

3 Undervalued Stocks in Berkshire's Portfolio

We think these holdings are bargains.

Mentioned: , , , , , , , , ,

Last week, Berkshire Hathaway (BRK.A) (BRK.B) released its third-quarter 13-F. Morningstar's resident Berkshire specialist, Gregg Warren, noted that there were a few surprises. Most notably, the firm scooped up four healthcare names--AbbVie (ABBV), Merck (MRK), Bristol-Myers Squibb (BMY), and Pfizer (PFE)--during the quarter. It also initiated new money positions in T-Mobile (TMUS), participated in the Snowflake (SNOW) IPO, and added to stakes in Kroger (KR), Liberty Latin America, and General Motors (GM).

As for sales, Berkshire haircut several positions in its banking stake, including JPMorgan Chase (JPM), PNC Financial (PNC), Wells Fargo (WFC), and M&T Bank (MTB). It also scaled back some in Barrick Gold (GOLD), Liberty Global (LBTYK), DaVita (DVA), and Axalta (AXTA).

Susan Dziubinski does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.